General - Press Releases

Date	Title	Company
19-Jul-2023	Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities	Businesswire
19-Jul-2023	MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction	Businesswire
19-Jul-2023	Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call	Businesswire
19-Jul-2023	FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis	Businesswire
19-Jul-2023	Global Permanent Magnets Market Analysis 2023-2030 - Rising Demand in Medical Devices and Smart Electronics Drives Growth - ResearchAndMarkets.com	Businesswire
19-Jul-2023	Aviceda Announces Podium Presentations on AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of Geographic Atrophy from Macular Degeneration, at American Society of Retina Specialists (ASRS) and the OIS Retina Innovation Summit Meetings	Businesswire
19-Jul-2023	Riparian Pharmaceuticals Announces Agreements with Pfizer for Novel Cardiovascular Programs	Businesswire
19-Jul-2023	Coya Therapeutics (“Coya”) Announces the Appointment of Dr. Merit Cudkowicz, M.D., M.Sc., as Clinical Advisor to Support the Development of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)	Businesswire
19-Jul-2023	GlycoMimetics to Report Second Quarter 2023 Financial Results on August 2, 2023	Businesswire
19-Jul-2023	Harrow Prices $60 Million Public Offering of Common Stock	Businesswire
19-Jul-2023	Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer	Businesswire
19-Jul-2023	Growing Demand for Algae Protein and Omega-3 Fatty Acids Drives Europe Microalgae Market to Reach $491.9 Million by 2030 - ResearchAndMarkets.com	Businesswire
19-Jul-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
19-Jul-2023	Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe	Businesswire
19-Jul-2023	Santen s’engage dans des accords de licence et de transfert d’actifs pour ses produits pharmaceutiques en Amérique du Nord	Businesswire
19-Jul-2023	Secretome Therapeutics Appoints Margot Connor as Board Director and Assembles World-Class Clinical Advisory Board	Businesswire
19-Jul-2023	KKR Leads US$190 million Series C Round in Leading Korean Online Platform MUSINSA	Businesswire
19-Jul-2023	Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America	Businesswire
19-Jul-2023	Harrow Acquires Santen’s Branded Ophthalmic Portfolio	Businesswire
18-Jul-2023	Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer	Businesswire